date:Apr 02, 2014
epresenting a current operating margin of 11.0% compared to 12.0% in 2012, and in line with results for the first three quarters of the year.
Consolidated operating profit totalled 34.5 million compared to 37.6 million in 2012 for an operating margin of 10.7% versus 12.5% in 2012. This result includes other non-current operating expenses of 0.8 million, up from 4.4 million one year earlier, mainly reflecting:
0.3 million in restructuring costs for Pektowin, significan